Cargando…
Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation
C-Met, the receptor of hepatocyte growth factor (HGF), through overexpression or mutation, is a major protooncogene that provides an attractive molecular target for cancer therapy. HGF/c-Met–induced tumorigenesis is dependent, in part, on the transcription factor and oncogene signal transducer and a...
Autores principales: | Kermorgant, Stéphanie, Parker, Peter J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528569/ https://www.ncbi.nlm.nih.gov/pubmed/18779368 http://dx.doi.org/10.1083/jcb.200806076 |
Ejemplares similares
-
c-Met-integrin cooperation: Mechanisms, tumorigenic effects, and therapeutic relevance
por: Stanislovas, Justas, et al.
Publicado: (2022) -
The Role of PI3K in Met Driven Cancer: A Recap
por: Hervieu, Alexia, et al.
Publicado: (2018) -
Unconventional role of RAC1 in MET-driven anchorage-independent tumor growth
por: Hervieu, Alexia, et al.
Publicado: (2020) -
The role of MET in chemotherapy resistance
por: Wood, Georgina E., et al.
Publicado: (2021) -
The clinical and functional significance of c-Met in breast cancer: a review
por: Ho-Yen, Colan M, et al.
Publicado: (2015)